Prime Medicine Inc (PRME)
7.43
-0.60
(-7.47%)
USD |
NASDAQ |
May 22, 16:00
7.43
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Assets (Quarterly): 311.38M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 311.38M |
| December 31, 2023 | 193.85M |
| September 30, 2023 | 239.14M |
| June 30, 2023 | 280.86M |
| March 31, 2023 | 316.95M |
| Date | Value |
|---|---|
| December 31, 2022 | 360.31M |
| September 30, 2022 | 215.26M |
| June 30, 2022 | 247.60M |
| December 31, 2021 | 301.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
193.85M
Minimum
Dec 2023
360.31M
Maximum
Dec 2022
274.14M
Average
280.86M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Pacific Biosciences of California Inc | 1.670B |
| 10x Genomics Inc | 922.91M |
| Recursion Pharmaceuticals Inc | 557.85M |
| Verve Therapeutics Inc | 732.36M |
| Ginkgo Bioworks Holdings Inc | 1.582B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.62M |
| Shareholders Equity (Quarterly) | 243.77M |
| Current Ratio | 8.905 |